Aryavan Enterprise Ltd
Incorporated in 1993, Ecofinity Atomix Ltd
is engaged in the business of trading goods.[1]
- Market Cap ₹ 36.8 Cr.
- Current Price ₹ 52.9
- High / Low ₹ 63.7 / 31.6
- Stock P/E 13.4
- Book Value ₹ 27.8
- Dividend Yield 0.95 %
- ROCE 18.1 %
- ROE 14.1 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 1,618 days to 136 days
Cons
- Promoter holding is low: 37.8%
- Company has a low return on equity of 8.96% over last 3 years.
- Earnings include an other income of Rs.2.65 Cr.
- Promoter holding has decreased over last 3 years: -26.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Products Iron & Steel Products
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.36 | 0.20 | 0.42 | 2.87 | 0.39 | 0.76 | 0.30 | 0.00 | 0.20 | 0.19 | 6.53 | 31.07 | 34.00 | |
| 0.29 | 0.13 | 0.44 | 2.92 | 0.46 | 0.77 | 0.42 | 0.15 | 0.27 | 0.52 | 6.47 | 29.81 | 33.00 | |
| Operating Profit | 0.07 | 0.07 | -0.02 | -0.05 | -0.07 | -0.01 | -0.12 | -0.15 | -0.07 | -0.33 | 0.06 | 1.26 | 1.00 |
| OPM % | 19.44% | 35.00% | -4.76% | -1.74% | -17.95% | -1.32% | -40.00% | 66.67% | -35.00% | -173.68% | 0.92% | 4.06% | 2.94% |
| 0.04 | 0.00 | -0.02 | 0.30 | 0.10 | 0.24 | 0.13 | 0.03 | 0.07 | 0.07 | 0.22 | 0.69 | 2.65 | |
| Interest | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.09 |
| Depreciation | 0.04 | 0.08 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.05 | -0.02 | -0.08 | 0.25 | 0.03 | 0.23 | 0.01 | -0.12 | 0.00 | -0.26 | 0.28 | 1.94 | 3.56 |
| Tax % | 40.00% | 50.00% | 0.00% | 8.00% | 33.33% | 30.43% | 0.00% | 0.00% | 0.00% | 3.57% | 21.13% | ||
| 0.04 | -0.03 | -0.08 | 0.23 | 0.02 | 0.15 | 0.01 | -0.13 | 0.00 | -0.26 | 0.27 | 1.52 | 2.74 | |
| EPS in Rs | 0.10 | -0.08 | -0.21 | 0.60 | 0.05 | 0.39 | 0.03 | -0.34 | 0.00 | -0.68 | 0.70 | 2.18 | 3.93 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 66% |
| 5 Years: | 153% |
| 3 Years: | 438% |
| TTM: | 38% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 49% |
| 5 Years: | 173% |
| 3 Years: | % |
| TTM: | 208% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 30% |
| 3 Years: | 30% |
| 1 Year: | 45% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 6% |
| 3 Years: | 9% |
| Last Year: | 14% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 3.85 | 6.96 | 6.96 |
| Reserves | -0.79 | -0.77 | -0.85 | -0.62 | -0.60 | -0.45 | -0.44 | -0.57 | -0.57 | -0.83 | -0.56 | 11.31 | 12.43 |
| 0.00 | 0.00 | 0.05 | 0.08 | 0.18 | 0.55 | 0.37 | 0.42 | 0.42 | 0.02 | 0.00 | 0.00 | 0.00 | |
| 0.97 | 1.11 | 0.09 | 0.91 | 1.06 | 0.65 | 0.83 | 0.17 | 0.12 | 0.00 | 2.42 | 0.32 | 0.28 | |
| Total Liabilities | 4.03 | 4.19 | 3.14 | 4.22 | 4.49 | 4.60 | 4.61 | 3.87 | 3.82 | 3.04 | 5.71 | 18.59 | 19.67 |
| 1.85 | 1.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.31 | 0.31 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.42 | 7.23 |
| 2.18 | 2.38 | 2.83 | 3.91 | 4.28 | 4.60 | 4.61 | 3.87 | 3.82 | 3.04 | 5.71 | 12.17 | 12.42 | |
| Total Assets | 4.03 | 4.19 | 3.14 | 4.22 | 4.49 | 4.60 | 4.61 | 3.87 | 3.82 | 3.04 | 5.71 | 18.59 | 19.67 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.50 | 0.02 | -0.58 | -2.03 | -0.31 | -0.38 | -0.08 | -0.12 | -0.02 | 0.30 | 0.14 | -7.31 | |
| 1.05 | 0.00 | 1.42 | 1.53 | 0.33 | 0.12 | 0.13 | 0.02 | 0.00 | 0.06 | 0.20 | -6.24 | |
| 1.46 | -0.01 | -0.35 | 0.02 | 0.10 | 0.37 | -0.19 | 0.05 | 0.00 | -0.40 | -0.02 | 13.46 | |
| Net Cash Flow | 0.00 | 0.01 | 0.48 | -0.47 | 0.12 | 0.11 | -0.13 | -0.05 | -0.01 | -0.04 | 0.31 | -0.09 |
| Free Cash Flow | -1.45 | 0.02 | 1.14 | -2.03 | -0.31 | -0.38 | -0.08 | -0.12 | -0.02 | 0.30 | 0.14 | -7.31 |
| CFO/OP | -3,543% | 43% | 2,900% | 4,060% | 443% | 3,100% | 67% | 80% | 29% | -91% | 250% | -556% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 385.28 | 1,003.75 | 451.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 117.38 | 91.04 | |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 60.54 | 0.00 | ||||
| Days Payable | 136.80 | |||||||||||
| Cash Conversion Cycle | 385.28 | 1,003.75 | 451.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 41.12 | 91.04 | |
| Working Capital Days | -192.64 | -273.75 | 373.69 | 331.93 | 2,339.74 | 1,488.82 | 3,966.33 | 4,635.50 | 4,552.89 | 164.89 | 136.27 | |
| ROCE % | 1.46% | -0.33% | -1.31% | 7.86% | 0.89% | 6.23% | 0.26% | -3.21% | 0.00% | -7.72% | 8.85% | 18.09% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Aug 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Number |
|
||||||||||
| Approved Solar Plant Capacity KW |
|||||||||||
| Projected Annual Solar Power Generation Lakhs KWH |
|||||||||||
| Subsidiary Ownership Stake (Padmavati Chemicals) Percentage (%) |
|||||||||||
Documents
Announcements
- Closure of Trading Window 30 Mar
-
Board Meeting Outcome for OUTCOME OF BOARD MEETING - ISSUE OF EQUITY WARRANTS
20 Feb - Proposal (20 Feb 2026) to issue 23,90,000 warrants (₹2.39 crore) preferentially; EGM for approval.
-
Board Meeting Intimation for Issue Of Shares.
17 Feb - Board meeting 20 Feb 2026 to consider preferential allotment; trading window closed 18-22 Feb.
-
Result - Financial Results For Quarter Ended 31/12/2025.
14 Feb - Board approved unaudited Q3 and nine-month results ended 31 Dec 2025; standalone net profit Rs84.66L, consolidated Rs81.30L.
-
Board Meeting Outcome for : Outcome Of The Board Meeting Held On Saturday, 14Th February, 2026 And Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Third Quarter And Nine Months Ended On 31St December, 2025
14 Feb - Approved unaudited standalone and consolidated Q3 and nine-month results for period ended 31-Dec-2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
Business Overview:[1]
EAL (Formerly known as Aryavan Enterprise
Limited) is Trader - Wholesaler /Distributor with a 60% Stake in Bulk Drug Intermediate Partnership Firm.